Skip to product information
1 of 1

LIGHT/TNFSF14 Protein, Human

LIGHT/TNFSF14 Protein, Human

Catalog Number: UA040546 Brand: UA BIOSCIENCE
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Tumor necrosis factor ligand superfamily member 14, Herpes virus entry mediator ligand (HVEM-L; Herpesvirus entry mediator ligand)
Accession O43557
Amino Acid Sequence

Asp74-Val240 with His Tag at the N-Terminus

Expression System HEK293
Molecular Weight

20-25, 40-42 kDa (Reducing)

Purity >95% by SDS-PAGE.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag His Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

J Clin Invest. 2001 Dec;108(12):1771-80.

Background

TNFSF14, also known as tumor necrosis factor ligand superfamily member 14 or LIGHT (homologous to lymphotoxins, exhibits inducible expression, and competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes), is a cytokine belonging to the tumor necrosis factor (TNF) superfamily. TNFSF14 is a type II transmembrane protein that can be cleaved to produce a soluble form. It functions as a ligand for two receptors, herpes virus entry mediator (HVEM) and lymphotoxin beta receptor (LTβR), and is involved in regulating immune responses, inflammation, and lymphoid organ development. TNFSF14 has been implicated in various physiological and pathological processes, including the modulation of T cell activation, the regulation of immune cell migration, and the promotion of antitumor immunity.

Picture

Bioactivity

Determined by its cytotoxic effect on HT-29 (human colon adenocarcinoma cells), the EC50 for this effect is less than 0.39ng/mL.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).